Letter from the Publisher

The Face of Integrative Oncology
by Mary Budinger
Many integrative cancer physicians incorporate insulin potentiation therapy (IPT), which uses insulin physiology to differentiate the cancer cell population from normal cells. But IPT is not what distinguishes the integrative cancer physician; the distinction starts with an attitude, as illustrated in this report from the 2012 International IPT/IPTLD Integrative Cancer Care Conference.

Patients with Metastatic Cancer Treated with Integrative Regulatory Therapies
by Leigh Erin Connealy, MD, and Francisco Contreras, MD
The authors employ an integration of conventional and alternative therapies at the Oasis of Hope Clinic in Irvine, California. Here they present statistics demonstrating improved long-term outcomes in patients with metastatic disease compared with conventional approaches.

Mark Rosenberg, MD: Integrative Cancer Research and Treatment
an interview with Nancy Faass, MSW, MPH
Dr. Rosenberg's work focuses on research in cancer and aging. The cancer research is concentrated on metabolic approaches to treatment, applying therapies that interfere with the metabolism of cancer cells.

Tocotrienols: Latest Cancer Research in Vitamin E
by Barrie Tan, PhD, and Anne M. Trias, MS
There hasn't been much good news about vitamin E lately; a large-scale clinical study even found that it increased the risk of prostate cancer. But the discredit of vitamin E applies only to alpha-tocopherol, which should not be confused with tocotrienol. This lesser-known form of vitamin E has repeatedly been shown to inhibit proliferation and induce cancer cell death.

The Clinical Evidence of Cellular Respiration to Target Cancer
by Professor Serge Jurasunas
Cellular respiration and the resulting consequences of this process is not a new theory that appears to be just now emerging but is in fact a very old story. Prof. Jurasunas presents his own experience, including discovery of a natural preparation that could not only regenerate the whole body but also target mitochondria, activate cellular respiration, and treat cancer.

Added online November 2016
An Alternative Therapeutic Approach to Various Cancers with Combinations of Chemotherapeutic Drugs or Vitamin C and D-Fraction
by Sensuke Konno, Bobby Alexander, and Muhammad Choudhury
This study investigated whether a variety of chemotherapeutic drugs could be potentiated with bioactive D-fraction (DF) extracted from maitake mushroom. DF appears to have a great potential as an adjuvant agent that can be combined with certain chemotherapeutic drugs or with vitamin C for the more effective treatment of various human malignancies.

Hyperthermia and Immunotherapy in the Treatment of Cancer:The Gorter Model
by Robert Gorter, MD, PhD, and Erik Peper, PhD
Hyperthermia can be provided in combination with a range of other therapies, both integrative and conventional. The Gorter Model is unique in the calibrated timing of hyperthermia and the dendritic cell vaccinations, which are augmented with other elements of the program, such as IV antioxidants, subcutaneous mistletoe injections, diet, and other lifestyle changes.

The Gerson Therapy and the Trophoblast Theory of Cancer Development
by Howard Straus
The Gerson Therapy is a holistic, nutritional, detoxifying therapy for cancer and other chronic diseases with a track record of over 80 years of success. A recent book by Nicholas Gonzalez and Linda Isaacs has shed additional light on the reasons behind the success of the therapy on a cellular level. Howard Straus, grandson of Dr. Max Gerson, had spirited and informative discussions with Dr. Gonzalez, resulting in the insights published in this article.

Targeting Galectin-3: A New Paradigm in Integrative Medicine
by Isaac Eliaz, MD, MS, LAc
Extensive published research shows that conditions such as metastatic cancer, chronic inflammation, and fibrosis share an aggressive biological culprit:excessgalectin-3. This molecule plays a dual role both as a diagnostic marker and an important therapeutic target. Studies are being funded by major medical institutes to investigate galectin-3 and modified citrus pectin– a proven natural galectin-3 inhibitor – in numerous chronic conditions.

The False Promises of Sunscreens: The Real Consequences of Their Use: Part 2
by Elizabeth Plourde, CLS, NCMP, PhD
Hormonally active chemicals in sunscreens may be one of the many environmental factors responsible for the growing numbers of children with autism and ADHD. And nanoparticles derived from metal oxides have been shown to harm aquatic life. Thus the use of sunscreens is an issue beyond personal health, affecting entire ecosystems and the well-being of future generations.

Jeffrey Bland, PhD: Lifestyle Medicine for Cancer and Other Chronic Conditions  
an interview with Nancy Faass, MSW, MPH
Many integrative physicians are already aware of the power of science-based lifestyle protocols to reduce or reverse chronic health conditions. These providers also walk the talk – many of them practice healthful lifestyle habits themselves; however, systematic integration of these principles into the clinical setting has been challenging. The essential elements of an effective lifestyle practice have not been fully realized until now.

Presentations at JAHC Discuss Relationship of Homeopathy to Allopathic Medicine
John Otrompke

Townsend Calendar

. . . the regular features, commentary and opinions we can count on each month from our distinguished columnists.